We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Sareum Holdings Plc | LSE:SAR | London | Ordinary Share | GB00BMC3RJ87 | ORD GBP 0.0125 |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
-3.00 | -8.96% | 30.50 | 30.00 | 31.00 | 38.00 | 30.50 | 37.50 | 3,267,070 | 14:39:50 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Pharmaceutical Preparations | 0 | -3.19M | -0.0469 | -6.50 | 20.76M |
Date | Subject | Author | Discuss |
---|---|---|---|
24/4/2024 22:53 | 737 is a great compound..that's why Sierra kept it sat on a shelf...and gsk handed it back..and there's been no updates on it.. You never answer my question... When is gsk buying sareum? Does emma walmsley know know? Or some of those people on LinkedIn.. | wolfofwallstreets | |
24/4/2024 22:53 | Sareum was turned down by the clinical trial authorisation (CTA) for SDC-1801 based on their submitted data package. The above 🙄 is a fact and here is another; It takes 10 to 15 years and around US$1 billion to develop one successful drug. Despite these significant investments in time and money, 90% of drug candidates in clinical trials fail! It beggars belief, the amount of misleading bullsh*it that Sadoldgit and co put up on LSE. They and I have no idea if Sareum will actually succeed and license one of their products, but let's be honest, it's very unlikely! A 10% chance at best and they've been trying for nearly 20 years. Now at Phase1 stage and this is only the start. The results won't tell us if it works. It's all an enormous gamble! Sadoldgit, if you're reading this I'm asking you politely, please STOP with the ramping. It's unfair to encourage new investors to part with their money based on your endless supply of nonsense. Peace ✌️ out | peaceandlove | |
24/4/2024 22:44 | I've answered you numerous times before. But you ignore my posts. Just bleat on with your lies...such as saying 737 wad a dead duck. YOU LIED! FACT! YOU JUST LIE! | criticalthinker1 | |
24/4/2024 22:40 | Criticalstinker...yo You said it... When are gsk buying aareum... Maybe emma walmsley can help you.. Nobody uses cheques anymore..it's 2024... It's out of date...like sareum... | wolfofwallstreets | |
24/4/2024 22:25 | Wolf you are a bit thick..but given the wrap bit I posted wasn't it a odd that some couldn't partake as they only had one share account despite years of share dealings...who in their right mind invests noteable amounts without multiple investment accounts? It is further noted that the WRAP Retail Offer is only open to investors in the United Kingdom who fall within Article 43 of the Financial Services and Markets Act 2000 (Financial Promotion) Order 2005, as amended (which includes an existing member of the Company). I will let you sleep on that point. I still keep my Coutts account open because I like the cheque book. Size of a slipper..just reminds me of old school banking days. | criticalthinker1 | |
24/4/2024 22:09 | Great post criticalstinker.. Emma walmsley said you should just mind your business and stop asking stupid questions... When's the gsk takeover happening? | wolfofwallstreets | |
24/4/2024 21:24 | Genuine question...why the stipulations on territories re the recent fundraiser? Important Notices The content of this announcement has been prepared by and is the sole responsibility of the Company This announcement and the information contained herein is not for release, publication or distribution, directly or indirectly, in whole or in part, in or into or from the United States (including its territories and possessions, any state of the United States and the District of Columbia (the "United States" or "US")), Australia, Canada, New Zealand, Japan, the Republic of South Africa, any member state of the EEA or any other jurisdiction where to do so might constitute a violation of the relevant laws or regulations of such jurisdiction. Especially given where our patents are approved and pending and also where trials are ongoing. Been scratching my head over this one. | criticalthinker1 | |
24/4/2024 19:51 | Peace. . You're a brave one for suggesting posting anything negative on lse... They want an echo chamber of imaginary takeovers and rerates and yachts and porches and 1 billion licence deals... I wish you well if you try... We can have bets on how fast it disappears! Have a good one! | wolfofwallstreets | |
24/4/2024 17:41 | Looks like investors 😂 are just realising full data isn't due for months not that any would understand the data anyway | iamhappy1 | |
24/4/2024 16:59 | 10% down...as I said... Doesn't take much for the weak and spineless happy clappers to disappear back under their rocks.. Always full of confidence when it rises... Watch the price fall on no news...or another placement.. Plus..lots of lovely new shares to come onto the market on Friday... Lol.. | wolfofwallstreets | |
24/4/2024 16:38 | Where's all the happy clappers gone?! | wolfofwallstreets | |
24/4/2024 16:21 | L2 HorrificallyHenry... | wolfofwallstreets | |
24/4/2024 15:59 | I don't think it would go as high as 5p... More like the 2p thoth2 always saw.. | wolfofwallstreets | |
24/4/2024 15:50 | 20 years of high salaries...bad decisions..ruinous financial arrangements...and no success... But lots of happy clappy ramping... | wolfofwallstreets | |
24/4/2024 15:45 | Ackers No proof of efficacy No license deal” Not from a friend but from the Bod | iamhappy1 | |
24/4/2024 15:40 | Cause you did ackkkers 😉 | peaceandlove | |
24/4/2024 15:11 | Henry...you OK? L2... Where have all the happy clappers gone.. | wolfofwallstreets | |
24/4/2024 14:38 | L2 HorrificallyHenry? | wolfofwallstreets |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions